Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

NCT06494397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar I Disorder

Interventions

DRUG: VHX-896 and iloperidone
DRUG: Iloperidone and VHX-896

Sponsor

Vanda Pharmaceuticals